In:
Epidemiology and Infection, Cambridge University Press (CUP), Vol. 150 ( 2022)
Kurzfassung:
At present, there is scarce evidence about the burden associated with the isolation of COVID-19 patients. We aimed to assess the differences between COVID-19 and other influenza-like illnesses (ILIs) in disease burden brought by isolation. We conducted an online survey of 302 respondents who had COVID-19 or other ILIs and compared the burden of isolation due to sickness with one-to-one propensity score matching. The primary outcomes are the duration and productivity losses associated with isolation, the secondary outcome is the health-related quality of life (HRQoL) valuation on the day of the survey. Acute symptoms of outpatient COVID-19 and other ILIs lasted 17 (interquartile range (IQR) 9–32) and 7 (IQR 4–10) days, respectively. The length of isolation due to COVID-19 was 18 (IQR 10–33) days and that due to other ILIs was 7 (IQR 4–11) days, respectively. The monetary productivity loss of isolation due to COVID-19 was 1424.3 (IQR 825.6–2545.5) USD and that due to other ILIs was 606.1 (IQR 297.0–1090.9) USD, respectively. HRQoL at the time of the survey was lower in the COVID-19 group than in the ‘other ILIs’ group (0.89 and 0.96, P = 0.001). COVID-19 infection imposes a substantial disease burden, even in patients with non-severe disease. This burden is larger for COVID-19 than other ILIs, mainly because the required isolation period is longer.
Materialart:
Online-Ressource
ISSN:
0950-2688
,
1469-4409
DOI:
10.1017/S0950268821002569
Sprache:
Englisch
Verlag:
Cambridge University Press (CUP)
Publikationsdatum:
2022
ZDB Id:
1470211-3
